Back to Results

Strive Inc (ASST)

Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks

Strive Inc (NASDAQ: ASST) is a common stock listing associated with Strive Asset Management, LLC, a privately owned investment manager based in Dallas, Texas. The firm was founded in 2022 and focuses primarily on serving investment companies. Its core role is as an investment adviser providing portfolio management services, supported by in-house research used in making investment decisions. Strive Asset Management’s investment activity includes exchange-traded funds, reflecting its role within the asset management and advisory segment of the financial industry.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-ASST
$11.10
-15.9% Downside
Fair
$29.60
124.2% Upside
Bargain
Weak
—
—
—
0.0%
September 2, 2026
-1.4x
1.4x
136.6x
901.8 M
1.193 B
1.0%
77.6%
18.0
-1.9%
9.8%
Send a message
Valuation • Fair Value

Strive Inc (NASDAQ-ASST) Fair Value by Valuation Model

Compare the primary fair value estimate for Strive Inc (NASDAQ-ASST) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$11.10

Estimated downside of 15.9% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

DCF Fair Value

$8.17

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$12.27

Comparable-company valuation reference.

Analyst Price Target

$29.60

Analysts imply upside of 124.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Strive Inc (NASDAQ-ASST) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Strive Inc (NASDAQ-ASST)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

7.071 M

Current operating scale indicator.

Revenue Forecast

12.114 M

Forward revenue estimate.

EBITDA

-561.4 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Strive Inc (NASDAQ-ASST) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Strive Inc (NASDAQ-ASST)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

18.0

Relatively strong balance-sheet zone.

FCF / Net Income

9.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Strive Inc (NASDAQ-ASST). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Strive Inc (NASDAQ-ASST)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 2, 2026

Days to Earnings

43

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

-1.9%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Strive Inc (NASDAQ-ASST), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Strive Inc (NASDAQ-ASST) Stock Forecast & Technical Outlook

Review Strive Inc (NASDAQ-ASST) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Strive Inc (NASDAQ-ASST) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Strive Inc (NASDAQ-ASST) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Strive Inc (NASDAQ-ASST) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Strive Inc (NASDAQ-ASST) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Strive Inc (NASDAQ-ASST) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Strive Inc (NASDAQ-ASST)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Strive Inc (NASDAQ-ASST) has a Strong Buy consensus, with 4 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 0
Sell 0
FAQ • Fast Investor Answers

Strive Inc (NASDAQ-ASST) Stock FAQ

Quick answers about Strive Inc (NASDAQ-ASST) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$11.10
Estimated downside 15.9%
Valuation Rating
Overvalued
Estimated downside of 15.9%
Analyst Target
$29.60
Implied upside 124.2%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Strive Inc (NASDAQ-ASST) is $11.10. This implies an estimated downside of 15.9% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 15.9% versus the current market price.

The available analyst price target for Strive Inc (NASDAQ-ASST) is $29.60. The analyst target implies estimated upside of 124.2%.

The current financial health read for Strive Inc (NASDAQ-ASST) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Strive Inc (NASDAQ-ASST) is September 2, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Strive Inc (NASDAQ-ASST) is -1.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Strive Inc is 901.8 M.

The current enterprise value listed for Strive Inc is 1.193 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Strive Inc is NASDAQ-ASST, and the stock is listed on NASDAQ.

Strive Inc (NASDAQ-ASST) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Strive Inc is 1.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Strive Inc is 77.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Equipment & Supplies Stocks on NASDAQ View more

Intuitive Surgical Inc (ISRG) Intuitive Surgical Inc (ISRG)
Medline Inc (MDLN) Medline Inc (MDLN)
IDEXX Laboratories Inc (IDXX) IDEXX Laboratories Inc (IDXX)
DexCom Inc (DXCM) DexCom Inc (DXCM)
GE HealthCare Technologies Inc (GEHC) GE HealthCare Technologies Inc (GEHC)
Cooper Companies Inc (COO) Cooper Companies Inc (COO)
Align Technology Inc (ALGN) Align Technology Inc (ALGN)
Insulet Corporation (PODD) Insulet Corporation (PODD)
Lantheus Holdings Inc (LNTH) Lantheus Holdings Inc (LNTH)
MiniMed Group Inc (MMED) MiniMed Group Inc (MMED)
Merit Medical Systems Inc (MMSI) Merit Medical Systems Inc (MMSI)
LivaNova PLC (LIVN) LivaNova PLC (LIVN)
ICU Medical Inc (ICUI) ICU Medical Inc (ICUI)
IRhythm Technologies Inc (IRTC) IRhythm Technologies Inc (IRTC)
Establishment Labs Holdings Inc (ESTA) Establishment Labs Holdings Inc (ESTA)
Dentsply Sirona Inc (XRAY) Dentsply Sirona Inc (XRAY)
TransMedics Group Inc (TMDX) TransMedics Group Inc (TMDX)
LeMaitre Vascular Inc (LMAT) LeMaitre Vascular Inc (LMAT)
Neogen Corporation (NEOG) Neogen Corporation (NEOG)
Axogen Inc (AXGN) Axogen Inc (AXGN)
Omnicell Inc (OMCL) Omnicell Inc (OMCL)
Pulse Biosciences Inc (PLSE) Pulse Biosciences Inc (PLSE)
UFP Technologies Inc (UFPT) UFP Technologies Inc (UFPT)
Novocure Ltd (NVCR) Novocure Ltd (NVCR)